Nektar Therapeutics (NASDAQ:NKTR) traded at $23.06 at close of the session on Friday, August 9 and m...
Nektar Therapeutics ( NASDAQ:NKTR ) Second Quarter 2025 Results Key Financial Results Revenue: US$11...
The company said it has sufficient financial resources to fund its operations into early 2027. Biote...
Among the strong points of Nektar Therapeutics Inc.’s atopic dermatitis (AD) prospect, rezpegaldesle...